Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)

FRA:818 Revenue

Zylox-Tonbridge Medical Technology had revenue of 481.97M CNY in the half year ending June 30, 2025, with 109.43% growth. This brings the company's revenue in the last twelve months to 898.46M, up 35.39% year-over-year. In the year 2024, Zylox-Tonbridge Medical Technology had annual revenue of 782.48M with 48.27% growth.

• Revenue (ttm): 898.46M CNY
• Revenue Growth: +35.39%
• P/S Ratio: 8.40
• Revenue / Employee: 1.03M CNY
• Employees: 875
• Market Cap: 896.55M EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	782.48M	254.72M	48.27%
Dec 31, 2023	527.75M	193.66M	57.97%
Dec 31, 2022	334.09M	156.18M	87.78%
Dec 31, 2021	177.91M	150.28M	543.89%
Dec 31, 2020	27.63M	22.71M	461.95%